Who are Investigational live attenuated mumps vaccine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Mumps vaccine, Live (MV), Yellow Fever 17DD Vaccine, Mumps vaccine, BCG solvent, MMR vaccine (Priorix), Rotarix TM.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/investigational-live-attenuated-mumps-vaccine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Investigational live attenuated mumps vaccine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigational live attenuated mumps vaccine (Investigational live attenuated mumps vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology.

phase 3 Live attenuated vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Investigational live attenuated mumps vaccine (Investigational live attenuated mumps vaccine) — Sinovac Research and Development Co., Ltd.. A live attenuated mumps vaccine stimulates the immune system to recognize and protect against mumps virus infection by using a weakened form of the virus.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Investigational live attenuated mumps vaccine TARGET	Investigational live attenuated mumps vaccine	Sinovac Research and Development Co., Ltd.	phase 3	Live attenuated vaccine
Mumps vaccine, Live (MV)	Mumps vaccine, Live (MV)	Sinovac Biotech Co., Ltd	marketed	Live attenuated vaccine
Yellow Fever 17DD Vaccine	Yellow Fever 17DD Vaccine	Centers for Disease Control and Prevention	marketed	live attenuated vaccine
Mumps vaccine	Mumps vaccine	Sinovac (Dalian) Vaccine Technology Co., Ltd.	marketed	Live attenuated vaccine	Mumps virus surface antigens
BCG solvent	BCG solvent	Bandim Health Project	marketed	Live attenuated vaccine
MMR vaccine (Priorix)	MMR vaccine (Priorix)	GlaxoSmithKline	marketed	Live attenuated vaccine
Rotarix TM	Rotarix TM	GlaxoSmithKline	marketed	Live attenuated vaccine	Rotavirus (RIX4414 strain)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Investigational live attenuated mumps vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-live-attenuated-mumps-vaccine. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab